Vaccine-Preventable Diseases in Older Adults

Area of Science:

• Gerontology
• Immunology
• Vaccinology

Background:

• Aging-related physiological changes increase older adults' susceptibility to vaccine-preventable diseases.
• Comorbidities in older populations further elevate infection vulnerability and diminish vaccine efficacy.
• Reduced immune response to vaccines in older individuals necessitates enhanced immunization strategies.

Purpose of the Study:

• To explore strategies for improving vaccine response in older adults.
• To address the challenges posed by age-related immune system decline.
• To identify methods for enhancing vaccine effectiveness in geriatric populations.

Main Methods:

• Investigated the use of higher antigenic doses in vaccines.
• Examined the role of adjuvants in modulating immune responses.
• Utilized high-dose inactivated influenza vaccines and adjuvanted inactivated influenza vaccines as examples.

Main Results:

• Higher antigenic doses, exemplified by high-dose inactivated influenza vaccines, are a strategy to improve vaccine response.
• Adjuvants, such as MF59 in adjuvanted inactivated influenza vaccines, can enhance vaccine efficacy.
• These strategies aim to overcome age-related reductions in vaccine effectiveness.

Conclusions:

• Employing higher antigenic doses and adjuvants are viable strategies to boost vaccine efficacy in older adults.
• These approaches can help mitigate the increased risk of vaccine-preventable diseases in this demographic.
• Further research into optimized vaccine formulations for the elderly is warranted.